TrialCell reports. Medicine2023
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy.
Steicy Sobrino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papertrialcites it